Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Alvotech, an independent sister company of the pharmaceutical company Alvogen, and Finesse Solutions Inc., a provider of turnkey single-use upstream bio-processing equipment, have formed a partnership under which Alvotech will...

biOasis Technologies Inc, a biopharmaceutical company focused on drug-delivery across the brain-blood barrier, has signed an evaluation agreement with MedImmune, the global biologics research and development arm of AstraZeneca. Under the agreement,...

Charles River Laboratories International, Inc. has entered into a definitive agreement to acquire the contract research organization (CRO) services division of Galapagos NV, which includes both Argenta and BioFocus, providers of integrated...

Aesica reports that its high-capacity manufacturing facility has been successfully validated for commercial production following a $45-million investment at its Queenborough, United Kingdom (UK) site. With the completion of this new...

Packaging Coordinators Inc. (PCI) has completed the planned expansion of its packaging facilities in Rockford, Illinois. The Rockford site is one of three locations in the United States, and the facilities expansion in Rockford was...

The private equity firm JLL Partners and Royal DSM have closed on their $2.65-billion deal, announced in November 2013, which combines DSM Pharmaceutical Products and Patheon Inc. into a new privately held company named DPx Holdings B.V....

Catalent Pharma Solutions has formed an agreement with the Center for iPS Cell Research and Application (CiRA) at Kyoto University in Japan to advance a regenerative human therapy with induced pluripotent stem (iPS) cells applicable to...

Debiopharm Group,  a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at...

The biopharmaceutical company Biodel Inc. has signed a long-term manufacturing agreement with Emergent BioSolutions under which Emergent will fill-finish commercial quantities of Biodel's glucagon emergency management (GEM)...

Parchem- fine & specialty chemicals, a supplier of active pharmaceutical ingredients, specialty intermediates, and excipients, has launched a new pharmaceutical division in Puerto Rico. Parchem's new pharmaceutical division will...

The global healthcare company Fresenius Kabi is establishing a $47-million pharmaceutical manufacturing facility and distribution center in Victoria, Australia, according to a press release by the Government of Victoria.  Fresenius Kabi...

Cobra Biologics and targeted cancer therapy company BioCancell have announced an agreement to manufacture BioCancell's BC-821 cancer drug for clinical trials. BioCancell's Phase I clinical trial for BC-821, scheduled to commence in 2015, is...

Dr. Hua Mu has been appointed senior vice-president of operations and global head of the product development service and partnership business unit at WuXi PharmaTech, reporting to Dr. Ge Li, chairman and chief executive officer. Dr. Mu has more...

Gallus BioPharmaceuticals (Gallus), a biologics contract manufacturing organization, has signed a manufacturing agreement with Symphogen, A/S (Symphogen), a private biopharmaceutical company developing recombinant monoclonal antibody (mAb) mixtures...